Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Cancer Discovery|May 3, 2017
A Road Map for Precision Cancer Medicine Using Personalized ModelsGabriele Picco, Mathew J GarnettDrug Discovery Today|February 21, 2012
Exploiting genetic complexity in cancer to improve therapeutic strategiesMathew J Garnett, Ultan McDermottCancer Cell|October 19, 2004
Guilty as charged: B-RAF is a human oncogeneMathew J Garnett, Richard MaraisCurrent Opinion in Genetics & Development|March 11, 2014
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug responseMathew J Garnett, Ultan McDermottPharmacogenomics|October 21, 2015
What role could organoids play in the personalization of cancer treatment?Hayley E Francies, Mathew J GarnettNature Cancer|February 5, 2022
Genomics-guided pre-clinical development of cancer therapiesHayley E Francies, Ultan McDermott, Mathew J GarnettCell Reports. Medicine|January 21, 2026
CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistanceAlex Watterson, Gabriele Picco, Vivien Veninga, et al.Genome Biology|April 27, 2026
BEstimate: a computational tool for the design and interpretation of CRISPR base editing experimentsCansu Dinçer, Bo Fussing, Mathew J Garnett, et al.Molecular Cell|December 21, 2005
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerizationMathew J Garnett, Sareena Rana, Hugh Paterson, et al.Genome Biology|January 22, 2021
Minimal genome-wide human CRISPR-Cas9 libraryEmanuel Gonçalves, Mark Thomas, Fiona M Behan, et al.Pageof 12